Wang, Chia-Ching <br/><br/>
Transient loss of detectable HIV-1 RNA following brentuximab vedotin anti-CD30 therapy for Hodgkin lymphoma.  [electronic resource] 

 -  Blood advances  12 2018 
 - 3479-3482 p.  digital 
<br/><br/> Publication Type: Case Reports; Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>2473-9537 
<br/><br/><label>Standard No.: </label>10.1182/bloodadvances.2018024364  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Anti-Retroviral Agents--therapeutic use<br/>Brentuximab Vedotin<br/>CD4-Positive T-Lymphocytes--cytology<br/>CD8-Positive T-Lymphocytes--cytology<br/>HIV Infections--drug therapy<br/>HIV-1--genetics<br/>Hodgkin Disease--complications<br/>Humans<br/>Immunoconjugates--therapeutic use<br/>Immunophenotyping<br/>Ki-1 Antigen--immunology<br/>Male<br/>RNA, Viral--blood